IL6 and endothelial dysfunction: Koudelka et al. demonstrated that decreasing ADMA levels and recovering eNOS expression could block the expression of IL-6 and ICAM-1, which improved the observed endothelial dysfunction and inflammatory processes in the lungs [42].